
CQC regulated clinic | Enjoy £10 off with code Welcome10
⚠️ Ordering Limits (from 1st Sept)
✅ You can only order from Lotus if you’ve had 2 pens or less in the last 28 days.
🚫 If you’ve already had 3 or more pens in the last 28 days, your order will be cancelled & refunded.
⏳ Please note: Due to high demand, orders may take up to 1-2 days to process.
Follow us on Instagram for updates.
1️⃣ Wegovy and Ozempic both contain the same active ingredient semaglutide, but they are designed for different purposes.
2️⃣ Wegovy is specifically approved for chronic weight management, while Ozempic is primarily for type 2 diabetes.
3️⃣ Dosing differs significantly: Wegovy’s higher dose (2.4 mg) leads to more substantial weight loss compared to Ozempic.
4️⃣ Side effects are similar, primarily gastrointestinal, but vary based on dosage.
5️⃣ Discontinuation of either medication often leads to weight regain, emphasizing the need for long-term management.
When considering weight loss treatments, it’s crucial to understand the differences between available options. Two medications often compared are Wegovy and Ozempic. Both contain the active ingredient semaglutide, a GLP-1 agonist that mimics a hormone involved in appetite regulation and blood sugar control.
While both drugs share a common component, their approved uses, dosing schedules, and weight loss efficacy differ significantly. For individuals seeking effective weight management solutions, these differences can be the deciding factor.
At Lotus Weight Loss Clinic, we offer Wegovy and Mounjaro to support your journey. Understanding which treatment suits your needs is essential, and that’s what this blog aims to clarify.
One of the fundamental differences between Wegovy and Ozempic is their primary indication.
For more information on the medications and pricing, visit our Medications and Pricing page.
The dosing schedules of these medications significantly impact their weight loss efficacy.
The higher dosage of Wegovy is specifically designed to maximize weight loss, while Ozempic’s lower dose limits its efficacy in this area.
Clinical studies indicate that Wegovy is more effective for weight management due to its higher dosing.
Both drugs work by mimicking the GLP-1 hormone, which reduces appetite and slows gastric emptying, leading to decreased food intake. However, the higher dose of Wegovy means it is more potent for weight loss.
Both medications can cause side effects such as nausea, diarrhea, constipation, and abdominal pain. These effects are more pronounced during dose escalation but usually diminish over time.
To learn more about managing these side effects and when to consider switching, visit our Switch Supplier page.
Regardless of the medication, sustainable weight loss often requires combining treatment with lifestyle changes like a balanced diet and regular exercise.
For individuals committed to long-term weight management, Wegovy is generally the better option, but Ozempic remains valuable for those focusing on diabetes control.
For personalised advice and support, visit our Thinking of Starting? page.
Choosing between Wegovy and Ozempic depends on your specific health goals—weight loss or diabetes management. Wegovy’s higher dosing makes it a superior choice for substantial weight loss, while Ozempic is beneficial primarily for diabetes control with some weight reduction potential. To maintain results, combining medication with healthy habits is crucial.
For more guidance, reach out through our Contact Us page.
Yes, switching may be beneficial if your primary goal is weight management. Consult your healthcare provider for personalized advice.
Weight regain is common if the medication is discontinued. Maintaining lifestyle changes can help mitigate this.
Both are generally safe when prescribed by a healthcare professional, but ongoing monitoring is important.
No, using both simultaneously is not recommended due to the risk of compounded side effects.
Gradual dose escalation and dietary adjustments can help manage nausea and gastrointestinal discomfort.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
(FDA – Official Label for Wegovy, including dosing and indications)
https://www.mayoclinic.org/drugs-supplements/semaglutide-subcutaneous-route/description/drg-20406730
(Mayo Clinic – Overview of Semaglutide and its uses)
https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/
(Drugs.com – Comparison of Wegovy, Ozempic, and Mounjaro for weight loss)
https://www.uchealth.org/today/wegovy-vs-ozempic-the-truth-about-new-weight-loss-drugs/
(UC Health – Comparison of Wegovy and Ozempic effectiveness)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080
(JAMA – Clinical analysis of weight loss outcomes with Wegovy and Ozempic)
https://www.ncbi.nlm.nih.gov/books/NBK603723/
(NCBI – Comprehensive analysis of semaglutide’s weight loss effectiveness)
https://www.webmd.com/obesity/mounjaro-ozempic-wegovy-zepbound-difference
(WebMD – Differences between Wegovy, Ozempic, and other similar medications)
https://www.wegovy.com/taking-wegovy/dosing-schedule.html
(Wegovy Official Site – Dosing schedule and titration information)
https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic
(European Medicines Agency – Ozempic’s EPAR document for safety and dosing)
Information
Need Help?
Instant answers
We’ll aim to reply within 2 hours
Open Mon- Fri 10am- 2pm
© 2025 Lotus Health Co. Ltd | Company Number: 13982460
Our CQC Number: 1-21252840589 | Our Partner Pharmacy is SignatureRx | GPhC Number: 9012267
Login to reorder..